Grimaud Brett A. sold TBPH
May 20, 2026 · Form 4 insider transaction
Grimaud Brett A. sold 8,829 shares of Theravance Biopharma, Inc. at $16.55 per share, a transaction worth $146.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,829
Price
$16.55
Total value
$146.1K
InsiderGrimaud Brett A.
RoleOfficer
SecurityOrdinary Shares
Transaction codeF: Shares withheld for taxes
Transaction dateMay 20, 2026
Filing dateMay 22, 2026
Shares owned after363,120
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.